Iris Eshed1,2, Amit Druyan3,4, Myriam Stern5,6, Eitan Giat3,4, Omer Gendelman4, Merav Lidar6,4. 1. Department of Diagnostic Imaging, Sheba Medical Center, 52621, Tel Hashomer, Israel. iriseshed@gmail.com. 2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. iriseshed@gmail.com. 3. Department of Medicine "F", Sheba Medical Center, Tel Hashomer, Israel. 4. Rheumatology Unit, Sheba Medical Center, Tel Hashomer, Israel. 5. Department of Diagnostic Imaging, Sheba Medical Center, 52621, Tel Hashomer, Israel. 6. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
OBJECTIVE: To evaluate the frequency of sacroiliitis in older subjects. MATERIALS AND METHODS: Consecutive MRI examinations of the sacroiliac joints (SIJs) performed for suspected sacroiliitis (2005-2019) in patients ≥ 18 years were retrospectively evaluated for the presence of active/structural lesions and were categorized for the presence/absence of sacroiliitis. Clinical and imaging parameters were compared between subjects with sacroiliitis according to age groups < 40 years, 40-55, and > 55 years. Clinical parameters including inflammatory back pain (IBP) and other spondyloarthritis (SpA) features were retrieved from the medical records. RESULTS: A total of 431 patients with SIJs MRI were evaluated: median age, 44 [IQR 35-54]; female:male 267(62%):164(38%). Sacroiliitis was diagnosed in 89 (20.6%) subjects-median age, 41 years [IQR 32-54], 52% females- and was equally prevalent among the different age groups: > 40 years old, 23.6%; 40-55, 20%; and > 55 years old, 17%, p = 0.43, with active/structural lesions equally dispersed. Older patients (> 55) started suffering from back pain at an older age and had a longer delay in diagnosis. Gender distribution, the presence of IBP, and other SpA features were no different in patients < 45 and > 55 years of age. CONCLUSIONS: The frequency of sacroiliitis on SIJs-MRI in subjects > 55 years is similar to its frequency in younger subjects and is associated with the same type and magnitude of active and structural MRI lesions. Clinical parameters such as IBP and additional SpA features are similarly prevalent in older and younger subjects suggesting they suffer from the same disease and differing only in age of presentation.
OBJECTIVE: To evaluate the frequency of sacroiliitis in older subjects. MATERIALS AND METHODS: Consecutive MRI examinations of the sacroiliac joints (SIJs) performed for suspected sacroiliitis (2005-2019) in patients ≥ 18 years were retrospectively evaluated for the presence of active/structural lesions and were categorized for the presence/absence of sacroiliitis. Clinical and imaging parameters were compared between subjects with sacroiliitis according to age groups < 40 years, 40-55, and > 55 years. Clinical parameters including inflammatory back pain (IBP) and other spondyloarthritis (SpA) features were retrieved from the medical records. RESULTS: A total of 431 patients with SIJs MRI were evaluated: median age, 44 [IQR 35-54]; female:male 267(62%):164(38%). Sacroiliitis was diagnosed in 89 (20.6%) subjects-median age, 41 years [IQR 32-54], 52% females- and was equally prevalent among the different age groups: > 40 years old, 23.6%; 40-55, 20%; and > 55 years old, 17%, p = 0.43, with active/structural lesions equally dispersed. Older patients (> 55) started suffering from back pain at an older age and had a longer delay in diagnosis. Gender distribution, the presence of IBP, and other SpA features were no different in patients < 45 and > 55 years of age. CONCLUSIONS: The frequency of sacroiliitis on SIJs-MRI in subjects > 55 years is similar to its frequency in younger subjects and is associated with the same type and magnitude of active and structural MRI lesions. Clinical parameters such as IBP and additional SpA features are similarly prevalent in older and younger subjects suggesting they suffer from the same disease and differing only in age of presentation.
Authors: T L Skare; N Leite; A B Bortoluzzo; C R Gonçalves; J A B da Silva; A C Ximenes; M B Bértolo; S L E Ribeiro; M Keiserman; R Menin; S Carneiro; V F Azevedo; W P Vieira; E das N Albuquerque; W A Bianchi; R Bonfiglioli; C Campanholo; H M S Carvalho; I P Costa; A P Duarte; M B O Gavi; C L Kohem; S A L Lima; E S Meirelles; I A Pereira; M M Pinheiro; E Polito; G G Resende; F A C Rocha; M B Santiago; M de F L C Sauma; P D Sampaio-Barros Journal: Clin Exp Rheumatol Date: 2012-06-25 Impact factor: 4.473